APA (7th ed.) Citation

Elizabeth K. Lee, Zhenying Tan-Wasielewski, Ursula A. Matulonis, Michael J. Birrer, Alexi A. Wright, Neil Horowitz, . . . Joyce F. Liu. (2019). Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. Elsevier.

Chicago Style (17th ed.) Citation

Elizabeth K. Lee, Zhenying Tan-Wasielewski, Ursula A. Matulonis, Michael J. Birrer, Alexi A. Wright, Neil Horowitz, Panagiotis A. Konstantinopoulos, Jennifer Curtis, and Joyce F. Liu. Results of an Abbreviated Phase Ib Study of the HDAC6 Inhibitor Ricolinostat and Paclitaxel in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Elsevier, 2019.

MLA (9th ed.) Citation

Elizabeth K. Lee, et al. Results of an Abbreviated Phase Ib Study of the HDAC6 Inhibitor Ricolinostat and Paclitaxel in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Elsevier, 2019.